A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer

British Journal of Cancer

Volumn 86, Issue 10, 2002, Pages 1551-1554

  Ikeda, M ^a   Okada, S ^a   Tokuuye, K ^a   Ueno, H ^a   Okusaka, T ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

CA19 9; Chemoradiotherapy; Gemcitabine; Pancreatic cancer

Indexed keywords

GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; BEAM THERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FATIGUE; FEMALE; HUMAN; MALE; NAUSEA; NEUTROPENIA; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH ULCER; VOMITING;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CA-19-9 ANTIGEN; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FATIGUE; FEMALE; HEPATITIS, TOXIC; HUMANS; LEUKOPENIA; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PALLIATIVE CARE; PANCREATIC NEOPLASMS; RADIOTHERAPY, HIGH-ENERGY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0037141347     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600256     Document Type: Article

References (19)

1. Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: A phase II study
2. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer
3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
4. Phase II trial of gemcitabine (2,2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas
5. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer
6. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone
7. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma
8. Radio-sensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine
9. Reporting results of cancer treatment
10. Combined 5-fluorourail and supervoltage radiation therapy of locally unresectable gastrointestinal cancer
11. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil
12. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial
13. Non-surgical treatments of pancreatic cancer
14. Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinoma
15. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
16. Gemcitabine and radiosensitization in human tumor cells
17. An investigational new drug treatment program for patients with gemcitabine: Results for over 3000 patients with pancreatic carcinoma
18. Eastern cooperative oncology group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity
19. End-joining deficiency and radiosensitization induced by gemcitabine